Clinical Care

Update as of January 2025:

We are no longer accepting new patients for cognitive evaluations or second opinions.

The MDP is focused on conducting research studies and clinical trials of new therapies to prevent or slow cognitive decline in Mild Cognitive Impairment and Alzheimer’s disease.

Patients seeking new patients appointments should contact central scheduling at 202-295-0540 (option 2).